Replimune (REPL) Short-term Investments (2018 - 2025)

Replimune has disclosed Short-term Investments across 8 years of filings, most recently posting $146.2 million for Q4 2025.

• Short-term Investments for Q4 2025 came in at $146.2 million, down 59.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $146.2 million (down 59.87% YoY), and the FY2025 annual result was $372.7 million, up 7.65% from the prior year.
• Short-term Investments came in at $146.2 million for Q4 2025 at Replimune, down from $221.3 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $436.8 million in Q1 2023 to a low of $146.2 million in Q4 2025.
• The 5-year median for Short-term Investments is $311.7 million (2024), against an average of $322.0 million.
• Across the five-year window, Short-term Investments jumped 169.39% in 2021 and plunged 59.87% in 2025, its largest moves.
• Replimune's Short-term Investments stood at $287.9 million in 2021, then surged by 42.31% to $409.7 million in 2022, then retreated by 10.01% to $368.7 million in 2023, then retreated by 1.19% to $364.3 million in 2024, then slumped by 59.87% to $146.2 million in 2025.
• The last three Short-term Investments figures came in at $146.2 million (Q4 2025), $221.3 million (Q3 2025), and $306.0 million (Q2 2025), per Business Quant data.